Vimarsana
Biggest News Aggregation in the World

Page 2 - Relapsing Forms News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Relapsing Forms. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Relapsing Forms Today - Breaking & Trending Today

Janssen Demonstrates Its Commitment to Advancing Transformative Solutions for Multiple Sclerosis at ACTRIMS Forum 2022 - Vimarsana News

Janssen Demonstrates Its Commitment to Advancing Transformative Solutions for Multiple Sclerosis at ACTRIMS Forum 2022

Published: February 22, 2022

/PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that 13 company-sponsored data presentations from its multiple...

Source: prnewswire.com
Related Topics:
United StatesWest Palm BeachPrinzj PonesimodJessica MooreBill MartinNone Of The Janssen Pharmaceutical CompaniesAmericas Committee For TreatmentJanssen Pharmaceuticals IncNational Multiple Sclerosis SocietyJanssen Research DevelopmentJanssen Pharmaceutical CompaniesJanssen Pharmaceutical Companies Of JohnsonActelion Pharmaceuticals LtdExchange CommissionCompanies Of JohnsonIdorsia Pharmaceuticals LtdResearch In Multiple SclerosisMultiple SclerosisGlobal Therapeutic Area HeadJanssen ResearchData Presentations IncludePatient PerspectivesPatient Burden RelatedHidden SymptomsNovel Patient Recruitment Strategy
Janssen: New Subgroup Analysis of the Phase 3 OPTIMUM Study Demonstrates the Benefits of PONVORYTM? (ponesimod) Over teriflunomide in Early Disease Multiple Sclerosis - Vimarsana News

Janssen: New Subgroup Analysis of the Phase 3 OPTIMUM Study Demonstrates the Benefits of PONVORYTM? (ponesimod) Over teriflunomide in Early Disease Multiple Sclerosis

Published: October 13, 2021

Early treatment in multiple sclerosis (MS) with higher-potency therapies can improve long-term patient outcomes1,2 New subgroup analysis of the pivotal Phase 3 OPTIMUM trial shows that MS patients

Source: finanznachrichten.de
Related Topics:
Janssen Cilag GmAlexandra NisipeanuJennifer McintyrePrinzj PonesimodJanssen Cilag InternationalNone Of The Janssen Pharmaceutical CompaniesEuropean CommissionNational Multiple Sclerosis SocietyJanssen Pharmaceutical CompaniesJanssen Pharmaceutical Companies Of JohnsonActelion Pharmaceuticals LtdExchange CommissionJanssen Global ServicesCompanies Of JohnsonIdorsia Pharmaceuticals LtdEuropean CommitteeTreatment ResearchMultiple SclerosisAbout Multiple SclerosisPharmaceutical CompaniesCardiovascular MetabolismInfectious Diseases VaccinesJanssen CilagConcerning Forward Looking StatementsPrivate Securities Litigation Reform Act